As I just mentioned, R&D expenses for the quarter include a one-time charge of acquired in-process R&D expenses of $24.6 million resulting from the recent non-cash asset acquisitions of Fortis Therapeutics.

Source: https://seekingalpha.com/article/4625157-fibrogen-inc-fgen-q2-2023-earnings-call-transcript?source=feed_all_articles

Bank of America decreased their price objective on Fortis from $38.00 to $37.00 in a report on Wednesday, September 20th.

Source: https://www.dailypolitical.com/2023/12/11/beutel-goodman-co-ltd-buys-43805-shares-of-fortis-inc-nysefts.html

Commenting on the same, Dr Satish Koul, director of Internal Medicine, Fortis Memorial Research Institute, Gurgaon told is caused by SARS-CoV-2 virus.

Source: https://indianexpress.com/article/lifestyle/health/centre-releases-new-covid-19-guidelines-for-adult-patients-8507692/

Finally, CIBC lifted their target price on Fortis from C$55.00 to C$57.00 in a research note on Tuesday, January 10th.

Source: https://www.etfdailynews.com/2023/03/30/crossmark-global-holdings-inc-buys-1792-shares-of-fortis-inc-nysefts/

Finally, Fortis Capital Advisors LLC increased its position in shares of iShares MSCI USA Momentum Factor ETF by 44.9% during the 1st quarter.

Source: https://www.dailypolitical.com/2023/10/21/tiaa-fsb-decreases-stock-holdings-in-ishares-msci-usa-momentum-factor-etf-batsmtum.html

Finally, Fortis Capital Advisors LLC purchased a new position in shares of Walt Disney in the fourth quarter worth $39,000.

Source: https://www.dailypolitical.com/2023/09/18/kathmere-capital-management-llc-buys-2137-shares-of-the-walt-disney-company-nysedis.html

Finally, Fortis Capital Advisors LLC purchased a new stake in shares of Leonardo DRS during the fourth quarter valued at about $65,000.

Source: https://www.etfdailynews.com/2023/10/01/leonardo-drs-nasdaqdrs-now-covered-by-analysts-at-bank-of-america/

Fortis Capital Advisors LLC acquired a new position in Micron Technology during the fourth quarter worth approximately $25,000.

Source: https://www.etfdailynews.com/2023/04/01/robert-w-baird-boosts-micron-technology-nasdaqmu-price-target-to-60-00/

Fortis Capital Advisors LLC bought a new stake in Encore Wire in the 4th quarter worth about $121,000.

Source: https://www.etfdailynews.com/2023/08/01/amalgamated-bank-lowers-holdings-in-encore-wire-co-nasdaqwire/

Fortis Capital Advisors LLC purchased a new position in shares of Coca-Cola in the fourth quarter worth about $30,000.

Source: https://www.americanbankingnews.com/2023/06/23/central-bank-trust-co-boosts-stake-in-the-coca-cola-company-nyseko.html

Fortis Capital Advisors LLC purchased a new stake in Novartis during the fourth quarter valued at about $27,000.

Source: https://www.etfdailynews.com/2023/08/13/novartis-ag-nysenvs-shares-sold-by-mirae-asset-global-investments-co-ltd/

Fortis Capital Advisors LLC purchased a new stake in The Ensign Group in the 4th quarter valued at about $26,000.

Source: https://www.americanbankingnews.com/2023/11/26/citigroup-inc-boosts-stock-position-in-the-ensign-group-inc-nasdaqensg.html

Fortis Group Advisors LLC purchased a new stake in shares of National Grid in the first quarter worth about $1,087,000.

Source: https://www.dailypolitical.com/2023/06/25/deutsche-bank-aktiengesellschaft-cuts-national-grid-nysengg-price-target-to-gbx-1050.html

Fortis has a one year low of $34.76 and a one year high of $46.28.

Source: https://www.etfdailynews.com/2023/09/24/bank-of-america-cuts-fortis-nysefts-price-target-to-37-00/

We have seen so many transplants for the blood cancers dealing with some of the other forms of back and forth infections,” Dr. Neha Rastogi Panda,Senior consultant Infectious disease at Fortis hospital, Gurugram, told IANS.

Source: https://www.canindia.com/will-stem-cell-transplant-be-a-game-changer-in-hiv-cure/

Yak led by as much as seven lengths in that time, but once the field hit the home straight it was all Semper Fortis.

Source: https://www.centralwesterndaily.com.au/story/8471866/semper-fortis-wins-angullong-wines-benchmark-66-handicap/?src=rss